Monday, June 15, 2026

Jaguar Land Rover Crowns Samsung SDI a Champion in EV Battery Tech

Samsung SDI wins the JLRQ Award from Jaguar Land Rover, recognizing its high-quality battery technology and strong partnership.

HIDING Piglet: Kim Jong Un Is Too Scared To Meet Trump, Snubbing Global Diplomacy For Cowardly Silence

Trump seeks a meeting with Kim Jong Un, but North Korea remains silent, raising questions about potential talks ahead.

U.S. Strategy Shift: How North Korea Gains Strategic Leverage Amid Military Rivalry

U.S. strategy shifts may fuel an arms race, empowering North Korea's influence and complicating security dynamics in the region.

Tag: Onconic Therapeutics

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Your Guide to Jaqbo: The New GERD Treatment Shaping the Future of Chronic Care

Onconic Therapeutics begins a Phase 3 trial for Jaqbo, aiming to expand GERD treatment options and enhance long-term management strategies.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.